Grotelueschen Catherine B MD is categorized under Doctors in Melrose Park, IL .
Grotelueschen Catherine B MD was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Catherine Grotelueschen at the company’s single location by writing to 675 West North Avenue # 303, Melrose Park, Illinois IL 60160 or by phoning (630) 932-2020. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Grotelueschen Catherine B MD |
| Contact Person: | Catherine Grotelueschen |
| Address: | 675 West North Avenue # 303, Melrose Park, Illinois 60160 |
| Phone Number: | (630) 932-2020 |
| Website Address: | advocatehealth.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Grotelueschen Catherine B MD was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Catherine Grotelueschen for inquiries that concern Grotelueschen Catherine B MD by calling the company number (630) 932-2020, as your correspondence is most welcome. Additionally, the physical location of the single location of Grotelueschen Catherine B MD can be found at the coordinates 41.908351,-87.842296 as well as the street address 675 West North Avenue # 303 in Melrose Park, Illinois 60160.
For its online presence, you may visit Grotelueschen Catherine B MD’s website at advocatehealth.com and engage with its social media outlets through on Twitter and on Facebook.